|
HDN-1 is a naturally occurring fungal
epipolythiodioxopiperazine / epipolythiopiperazine-2,5-dione
(ETP) isolated from the Antarctic fungus
Oidiodendron truncatum GW3-13. HDN-1 has demonstrated preclinical
anticancer activity and acts as a direct Hsp90 inhibitor,
binding the C-terminal region of Hsp90α. Hsp90 inhibition by HDN-1 promotes
degradation of multiple oncogenic client proteins, enhances downregulation of
wild-type and mutant EGFR and suppresses tumour-cell proliferation. HDN-1 has
also induced differentiation followed by apoptosis in selected promyelocytic
leukemia cell lines. Its mechanism overlaps with that of the structurally
related ETP chaetocin, which also inhibits Hsp90, but HDN-1 and chaetocin are
chemically distinct compounds and should be maintained as separate products.
HDN-1 should be classified as an experimental natural fungal metabolite
/ epipolythiodioxopiperazine / Hsp90 inhibitor, with current anticancer
evidence predominantly preclinical.
HDN-1 is an analogue of chaetocin, which is a fungal mycotoxin with histone methyltransferase SUV39H1 inhibitory activity
|